- Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
- Tyra Biosciences to Present at Upcoming Investor Conferences
- Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
- Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
- Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
More ▼
Key statistics
On Friday, Tyra Biosciences Inc (TYRA:NSQ) closed at 14.98, 44.32% above the 52 week low of 10.38 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.60 |
---|---|
High | 14.99 |
Low | 14.35 |
Bid | 14.26 |
Offer | 15.65 |
Previous close | 14.66 |
Average volume | 134.48k |
---|---|
Shares outstanding | 52.52m |
Free float | 49.36m |
P/E (TTM) | -- |
Market cap | 769.96m USD |
EPS (TTM) | -1.62 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:00 BST.
More ▼